NCT02137369View on ClinicalTrials.gov

The ISLAND Study: InSuLa Assessed Needs for Depression

PHASE4CompletedINTERVENTIONAL
Enrollment

77

Participants

Timeline

Start Date

September 30, 2014

Primary Completion Date

October 24, 2019

Study Completion Date

October 24, 2019

Conditions
Depression
Interventions
DRUG

Selective serotonin re-uptake inhibitor

Escitalopram, 20mg-40mg daily or Sertraline 50-150 mg daily for 12 weeks

BEHAVIORAL

Cognitive Behavioral Therapy

Cognitive Behavioral Therapy, standardized, 16 sessions over 12 weeks.

OTHER

Combination treatment (SSRI + CBT)

study participants who do not remit in the first 12 weeks will be offered combination treatment of both treatments for 12 more weeks.

Trial Locations (1)

30329

12 Executive Park Drive, 3rd floor, Atlanta

All Listed Sponsors
collaborator

National Institute of Mental Health (NIMH)

NIH

lead

Emory University

OTHER

NCT02137369 - The ISLAND Study: InSuLa Assessed Needs for Depression | Biotech Hunter | Biotech Hunter